Search Results - "Pette, M."

Impact of genetic background on placental glycogen storage in mice by Tunster, S.J, Van de Pette, M, John, R.M

“…Abstract 129 and C57BL/6 are two of the most widely used laboratory mouse strains. While it is well known that genetic modifiers between the two strains can…”
Get full text

BACs as Tools for the Study of Genomic Imprinting by Tunster, S. J., John, R. M., Van De Pette, M.

“…Genomic imprinting in mammals results in the expression of genes from only one parental allele. Imprinting occurs as a consequence of epigenetic marks set down…”
Get full text

Myelin Autoreactivity in Multiple Sclerosis: Recognition of Myelin Basic Protein in the Context of HLA-DR2 Products by T Lymphocytes of Multiple- Sclerosis Patients and Healthy Donors by Pette, Martin, Fujita, Kyoko, Wilkinson, David, Altmann, Daniel M., Trowsdale, John, Giegerich, Gerhard, Hinkkanen, Ari, Epplen, Jorg T., Kappos, Ludgwig, Wekerle, Hartmut

“…A panel of 20 human myelin basic protein (hMBP)-specific T-lymphocyte lines was generated from the peripheral blood of eight multiple sclerosis (MS) patients…”
Get full text

Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals by PETTE, M, FUJITA, K, KITZE, B, WHITAKER, J. N, ALBERT, E, KAPPOS, L, WEKERLE, H

“…We derived a total of 146 T lymphocyte lines specific for human myelin basic protein (MBP) from the peripheral blood of 20 MS patients and from a control group…”
Get full text

Interferon-β interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes by PETTE, M, PETTE, D. F, MURARO, P. A, FARNON, E, MARTIN, R, MCFARLAND, H. F

“…Interferon-beta (IFN-beta) has beneficial effects on the frequency and severity of relapses, as well as on disease progression in patients suffering from…”
Get full text

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations by Wiendl, H., Toyka, K. V., Rieckmann, P., Gold, R., Hartung, H.-P., Hohlfeld, R.

“…This review updates and extends earlier Consensus Reports related to current basic and escalating immunomodulatory treatments in multiple sclerosis (MS). The…”
Get full text

Wirkmechanismen, unerwünschte Wirkungen und praktische Handhabung immunmodulierender Pharmaka in der Behandlung der Myasthenia gravis by Pette, M

“…Die Myasthenia gravis (MG) ist eine Autoimmunerkrankung, bei der polyklonale IgG-Autoantikörper mit den postsynaptischen Acetylcholin-Rezeptoren der…”
Get full text

Covalent Three-Dimensional Titanium(IV)−Aryloxide Networks by Vaid, Thomas P, Tanski, Joseph M, Pette, John M, Lobkovsky, Emil B, Wolczanski, Peter T

“…Ti(iOPr)4 was treated with 2.58 equiv of hydroquinone in THF to yield a red-orange powder formulated as [Ti(OC6H4O) a (OC6H4OH)3.34 - 1.83 a (OiPr)0.66 - 0.17…”
Get full text

T cell antigenic and neuritogenic activity of recombinant human peripheral myelin P2 protein by Weishaupt, A., Giegerich, G., Jung, S., Gold, R., Enders, U., Pette, M., Hayasaka, K., Hartung, H.-P., Toyka, K.V.

“…The major neuritogenic protein of peripheral nerve myelin is the P2 protein. Human P2 is a candidate autoantigen in inflammatory demyelinating diseases of the…”
Get full text

T lymphocyte recognition sites on peripheral nerve myelin P0 protein by Pette, M, Linington, C, Gengaroli, C, Grosse-Wilde, H, Toyka, K V, Hartung, H P

“…Synthetic peptides corresponding to the extracellular and cytoplasmic domain of bovine (b) or rat (r) peripheral myelin P0 protein were used to establish a…”
Get more information

Human T lymphocytes distinguish bovine from human P2 peripheral myelin protein: implications for immunological studies on inflammatory demyelinating neuropathies by Pette, M, Gengaroli, C, Hartung, H P, Greiner, A, Giegerich, G, Toyka, K V

“…In patients with inflammatory demyelinating neuropathy, which is possibly mediated by autoreactive, myelin-specific T lymphocytes, most studies focusing on…”
Get more information

Measles virus-directed responses of CD4+ T lymphocytes in MS patients and healthy individuals by PETTE, M, LIEBERT, U. G, GÖBEL, U, GROSSE-WILDE, H, HARTUNG, H.-P, TOYKA, K. V

“…To analyze the antigen specificities of measles virus (MV)-reactive CD4+ T cells in multiple sclerosis (MS) patients as compared with those of healthy donors,…”
Get full text

Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood by Kruse, Niels, Pette, Martin, Toyka, Klaus, Rieckmann, Peter

“…In order to facilitate cytokine mRNA detection in blood cells, we have developed a highly reproducible and easily performed RNA isolation method for use with…”
Get full text

Escalating immunotherapy of multiple sclerosis: New aspects and practical application by Rieckmann, P, Toyka, K V, Bassetti, C, Beer, K, Beer, S, Buettner, U, Chofflon, M, Götschi-Fuchs, M, Hess, K, Kappos, L, Kesselring, J, Goebels, N, Ludin, H-P, Mattle, H, Schluep, M, Vaney, C, Baumhackl, U, Berger, T, Deisenhammer, F, Fazekas, F, Freimüller, M, Kollegger, H, Kristoferitsch, W, Lassmann, H, Markut, H, Strasser-Fuchs, S, Vass, K, Altenkirch, H, Bamborschke, S, Baum, K, Benecke, R, Brück, W, Dommasch, D, Elias, W G, Gass, A, Gehlen, W, Haas, J, Haferkamp, G, Hanefeld, F, Hartung, H-P, Heesen, C, Heidenreich, F, Heitmann, R, Hemmer, B, Hense, T, Hohlfeld, R, Janzen, R W C, Japp, G, Jung, S, Jügelt, E, Koehler, J, Kölmel, W, König, N, Lowitzsch, K, Manegold, U, Melms, A, Mertin, J, Oschmann, P, Petereit, H-F, Pette, M, Pöhlau, D, Pohl, D, Poser, S, Sailer, M, Schmidt, S, Schock, G, Schulz, M, Schwarz, S, Seidel, D, Sommer, N, Stangel, M, Stark, E, Steinbrecher, A, Tumani, H, Voltz, R, Weber, F, Weinrich, W, Weissert, R, Wiendl, H, Wiethölter, H, Wildemann, U, Zettl, U K, Zipp, F, Zschenderlein, R, Izquierdo, G, Kirjazovas, A, Packauskas, L, Miller, D, Koncan Vracko, B, Millers, A, Orologas, A, Panellus, M, Sindic, C J M, Bratic, M, Svraka, A, Vella, N R, Stelmasiak, Z, Selmaj, K, Bartosik-Psujik, H, Mitosek-Szewczyk, K

“…Recent clinical studies in multiple sclerosis (MS) provide new data on the treatment of clinically isolated syndromes, on secondary progression, on direct…”
Get full text

Side effects of intravenous immunoglobulins in neurological autoimmune disorders: A prospective study by STANGEL, Martin, KIEFER, Reinhard, PETTE, Martin, SMOLKA, Michael N, MARX, Peter, GOLD, Ralf

“…The increased use of intravenous immunoglobulins (IVIg) in the treatment of neurological autoimmune diseases has led to more awareness of adverse reactions. We…”
Get full text

Myelin-specific T lymphocytes in multiple sclerosis patients and healthy individuals by Kitze, B, Pette, M, Rohrbach, E, Städt, D, Kappos, L, Wekerle, H

Get more information

Multiple-Sklerose-Dokumentationssystem 3D: Von der Dokumentation zum Patientenmanagement by Schultheiß, T., Kempcke, R., Kratzsch, F., Eulitz, M., Pette, M., Reichmann, H., Ziemssen, T.

“…Zusammenfassung Hintergrund Das sich stetig vergrößernde Spektrum von Behandlungsoptionen der Multiplen Sklerose (MS) erfordert ein spezifisches Therapie- und…”
Get full text

Multiple sclerosis management system 3D. Moving from documentation towards management of patients by Schultheiss, T, Kempcke, R, Kratzsch, F, Eulitz, M, Pette, M, Reichmann, H, Ziemssen, T

“…The increasing therapeutic options for relapsing-remitting multiple sclerosis require a specific treatment and risk management to recognize the individual…”
Get full text

Das Multiple-Sklerose-Dokumentationssystem MSDS by Pette, M., Eulitz, M.

Get full text

The Multiple Sclerosis Documentation System MSDS. Discussion of a documentation standard for multiple sclerosis by Pette, M, Eulitz, M

“…The MSDS (multiple sclerosis documentation system) has been developed at the Department of Neurology, Technical University of Dresden, Germany, during the last…”
Get full text